Zacks Investment Research lowered shares of Tate & Lyle (OTCMKTS:TATYY) from a buy rating to a hold rating in a research note published on Wednesday morning.
According to Zacks, “Tate & Lyle Ventures and Agri Investment Fund have co-led a 3.5m investment into Fugeia, a newly formed functional food technology business with a focus on gut health. “
Other analysts also recently issued research reports about the stock. ValuEngine raised shares of Tate & Lyle from a sell rating to a hold rating in a report on Tuesday, May 29th. Jefferies Financial Group downgraded shares of Tate & Lyle from a buy rating to a hold rating in a report on Wednesday, June 13th. One analyst has rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company. The stock presently has a consensus rating of Hold and an average target price of $38.00.
OTCMKTS TATYY opened at $33.15 on Wednesday. The stock has a market capitalization of $3.88 billion, a price-to-earnings ratio of 12.46, a price-to-earnings-growth ratio of 4.06 and a beta of 0.46. Tate & Lyle has a 12-month low of $29.39 and a 12-month high of $38.25.
The company also recently declared a Semi-Annual dividend, which was paid on Monday, August 13th. Stockholders of record on Friday, June 22nd were issued a dividend of $1.043 per share. The ex-dividend date of this dividend was Thursday, June 21st. Tate & Lyle’s dividend payout ratio (DPR) is presently 76.32%.
Tate & Lyle Company Profile
Tate & Lyle Plc engages in the provision of ingredients and solutions to the food, beverage and other industries. It operates through the following segments: Food & Beverage Solutions, Sucralose, and Primary Products. The Food & Beverage Solutions and Sucralose segment provides solutions for customers that meet consumer demand for healthier and tastier food and drink.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter.